{{Rsnum
|rsid=2242447
|Gene=SLC6A2
|Chromosome=16
|position=55702000
|Orientation=plus
|GMAF=0.4463
|Gene_s=SLC6A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 43.8 | 48.2
| HCB | 13.1 | 52.6 | 34.3
| JPT | 14.3 | 50.0 | 35.7
| YRI | 68.3 | 29.6 | 2.1
| ASW | 49.1 | 41.8 | 9.1
| CHB | 13.1 | 52.6 | 34.3
| CHD | 19.4 | 48.1 | 32.4
| GIH | 29.7 | 42.6 | 27.7
| LWK | 82.2 | 16.8 | 0.9
| MEX | 3.4 | 31.0 | 65.5
| MKK | 65.8 | 31.0 | 3.2
| TSI | 3.9 | 42.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23052569
|Title=A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD
}}

{{PMID Auto
|PMID=23872233
|Title=The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample
}}

{{PMID Auto
|PMID=17994190
|Title=Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
}}

{{PMID Auto
|PMID=19693267
|Title=Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}